ATLN Q4 2025 Earnings Significant EPS Miss Despite Stock Rally CIB Q4 2025 Earnings Massive EPS Miss as Company Reports Deep Loss Lufax Q3 2024 Earnings Massive EPS Miss Highlights Persistent Headwinds CENT Q1 2026 Earnings EPS Surprises to the Upside Stock Moves Higher Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount Host Hotels Resorts HST Q1 2026 Earnings A Stellar EPS Beat Fuels Market Optimism